Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4637348
Max Phase: Preclinical
Molecular Formula: C24H19N7O4
Molecular Weight: 469.46
Molecule Type: Unknown
Associated Items:
ID: ALA4637348
Max Phase: Preclinical
Molecular Formula: C24H19N7O4
Molecular Weight: 469.46
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cccc(Nc2nc3nonc3nc2N/N=C/c2ccc(-c3cccc(C(=O)O)c3)o2)c1C
Standard InChI: InChI=1S/C24H19N7O4/c1-13-5-3-8-18(14(13)2)26-20-21(28-23-22(27-20)30-35-31-23)29-25-12-17-9-10-19(34-17)15-6-4-7-16(11-15)24(32)33/h3-12H,1-2H3,(H,32,33)(H,26,27,30)(H,28,29,31)/b25-12+
Standard InChI Key: ONXLPQBYPUBYEJ-BRJLIKDPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 469.46 | Molecular Weight (Monoisotopic): 469.1499 | AlogP: 4.78 | #Rotatable Bonds: 7 |
Polar Surface Area: 151.56 | Molecular Species: ACID | HBA: 10 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.96 | CX Basic pKa: 2.41 | CX LogP: 5.16 | CX LogD: 2.12 |
Aromatic Rings: 5 | Heavy Atoms: 35 | QED Weighted: 0.22 | Np Likeness Score: -1.44 |
1. Peery R, Kyei-Baffour K, Dong Z, Liu J, de Andrade Horn P, Dai M, Liu JY, Zhang JT.. (2020) Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation., 63 (13): [PMID:32421328] [10.1021/acs.jmedchem.0c00475] |
Source(1):